Cellectar Biosciences Inc - Company Profile
Powered by 
All the data and insights you need on Cellectar Biosciences Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Cellectar Biosciences Inc Strategy Report
- Understand Cellectar Biosciences Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Cellectar Biosciences Inc (Cellectar) focuses on discovery, development and commercialization of cancer drugs. The company develops novel drugs for the diagnosis and treatment of cancer using the cancer-targeting technology, PDC platform. Cellectar’s proprietary phospholipid drug conjugate (PDC) platform is based on cancer-targeting and delivery and offers a broad range of oncologic payloads to cancer cells and cancer stem cells. Its therapeutic compounds kill cancer cells directly without harming the normal cells.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer